Back to Results
First PageMeta Content



MEROZYNE THERAPEUTICS Press release Lund, Sweden – May 27, 2015 Merozyne Therapeutics AB today announces that it has started a project aiming to develop a pharmaceutical treatment against laminin alpha2 chain-deficient
Add to Reading List

Document Date: 2015-05-27 04:19:47


Open Document

File Size: 91,92 KB

Share Result on Facebook
UPDATE